ArticleOncotarget2015

EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas.

N Perez-Janices et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.